The goal of the Neurogenomics Core is to provide the most advanced genomics and epigenomics assays and analyses to support the neurological and neuroscience research goals of the IDDRC community at the RFK-IDDRC. Modern neuroscience and neurology research has an increasing need for sophisticated genome-wide genetic and epigenetic assays in the quest to understand not only disease states but also the normal functioning of the nervous system. With the goals for the IDDRC encompassing areas such as the study of the pathogenesis of autism, the links between nutrition, obesity and brain development, deafness and communication disorders, and the pathogenesis of neurogenetic disorders, both genetic and epigenetic influences are obvious potential factors that must be considered. A strong cutting-edge Neurogenomics Core that supplies access to the most up-to-date sophisticated genomic technologies in a cost-effective and efficient manner is therefore an essential resource within a Center such as this. We will describe how we have assembled, integrated and extended resources across a system of existing core facilities to serve the specific neurogenetic needs of the IDDRC community at Einstein, leveraging the investment of the IDDRC to provide a powerful integrated readily accessible core facility that allows even the most inexperienced users to perform studies productively and successfully. The resources to be assembled are from multiple existing core facilities at Einstein, all developed and run by the Department of Genetics and the Center for Epigenomics. The leadership for this core is drawn from both of these entities, reflecting their commitment to the success of this core within the IDDRC. The Neurogenomics Core Facility will serve the needs of IDDRC investigators.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Center Core Grants (P30)
Project #
5P30HD071593-04
Application #
8734922
Study Section
Special Emphasis Panel (ZHD1-DSR-Y)
Project Start
Project End
Budget Start
2014-07-01
Budget End
2015-06-30
Support Year
4
Fiscal Year
2014
Total Cost
$123,888
Indirect Cost
$49,703
Name
Albert Einstein College of Medicine
Department
Type
DUNS #
110521739
City
Bronx
State
NY
Country
United States
Zip Code
10461
Boudewyn, Lauren C; Sikora, Jakub; Kuchar, Ladislav et al. (2017) N-butyldeoxynojirimycin delays motor deficits, cerebellar microgliosis, and Purkinje cell loss in a mouse model of mucolipidosis type IV. Neurobiol Dis 105:257-270
Pera, Marta; Larrea, Delfina; Guardia-Laguarta, Cristina et al. (2017) Increased localization of APP-C99 in mitochondria-associated ER membranes causes mitochondrial dysfunction in Alzheimer disease. EMBO J 36:3356-3371
Melentijevic, Ilija; Toth, Marton L; Arnold, Meghan L et al. (2017) C. elegans neurons jettison protein aggregates and mitochondria under neurotoxic stress. Nature 542:367-371
Kikusui, Takefumi; Hiroi, Noboru (2017) A Self-Generated Environmental Factor as a Potential Contributor to Atypical Early Social Communication in Autism. Neuropsychopharmacology 42:378
Saied-Santiago, Kristian; Townley, Robert A; Attonito, John D et al. (2017) Coordination of Heparan Sulfate Proteoglycans with Wnt Signaling To Control Cellular Migrations and Positioning in Caenorhabditis elegans. Genetics 206:1951-1967
Ray, Alex K; DuBois, Juwen C; Gruber, Ross C et al. (2017) Loss of Gas6 and Axl signaling results in extensive axonal damage, motor deficits, prolonged neuroinflammation, and less remyelination following cuprizone exposure. Glia 65:2051-2069
Zheng, Chaogu; Diaz-Cuadros, Margarete; Nguyen, Ken C Q et al. (2017) Distinct effects of tubulin isotype mutations on neurite growth in Caenorhabditis elegans. Mol Biol Cell 28:2786-2801
Wang, Ping; Mokhtari, Ryan; Pedrosa, Erika et al. (2017) CRISPR/Cas9-mediated heterozygous knockout of the autism gene CHD8 and characterization of its transcriptional networks in cerebral organoids derived from iPS cells. Mol Autism 8:11
Thomsen, Anna M; Gulinello, Maria E; Wen, Jing et al. (2017) Liposomal Cytarabine Induces Less Neurocognitive Dysfunction Than Intrathecal Methotrexate in an Animal Model. J Pediatr Hematol Oncol :
Sikora, Jakub; Dworski, Shaalee; Jones, E Ellen et al. (2017) Acid Ceramidase Deficiency in Mice Results in a Broad Range of Central Nervous System Abnormalities. Am J Pathol 187:864-883

Showing the most recent 10 out of 119 publications